Use of Serum Protein Measurements as Biomarkers That Can Predict the Outcome of Diabetic Foot Ulceration-Reference-Cited by-同舟云学术

Use of Serum Protein Measurements as Biomarkers That Can Predict the Outcome of Diabetic Foot Ulceration

Published:2024-01-23 Issue: Volume: Page:
ISSN:2162-1918
Container-title:Advances in Wound Care
language:en
Short-container-title:Advances in Wound Care

Author:

Theocharidis Georgios¹,Sumpio Brandon²,Wang Enya²,Mezghani Ikram²,Giurini John³,Kalavros Nikolaos³,Valsami Eleftheria Angeliki⁴,Vlachos Ioannis³,Heydarpour Mahyar⁵,Veves Aristidis⁶⁷

Affiliation:

1. Beth Israel Deaconess Medical Center, 1859, Rongxiang Xu Center for Regenerative Therapeutics, DA-811, 330 Brookline Ave, Boston, Massachusetts, United States, 02215, ;

2. Beth Israel Deaconess Medical Center, 1859, Rongxiang Xu Center for Regenerative Therapeutics, Boston, Massachusetts, United States;

3. Beth Israel Deaconess Medical Center, 1859, Boston, Massachusetts, United States;

4. Beth Israel Deaconess Medical Center, 1859, Rongxiang Xu Center for Regenerative Therapeutics, Boston, Massachusetts, United States, ;

5. Brigham and Women's Hospital, 1861, Boston, Massachusetts, United States;

6. Beth Israel Deaconess Medical Center, 1859, PA321A,, One Deaconess Road, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States, 02215,

7. Beth Israel Deaconess Medical Center - Harvard Medical School;

Publisher

Mary Ann Liebert Inc

Subject

Critical Care and Intensive Care Medicine,Emergency Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/wound.2023.0126

Reference16 articles.

1. Diabetic Foot Ulcers and Their Recurrence

2. Burden of Diabetic Foot Ulcers for Medicare and Private Insurers

3. Efficacy and Safely of a Topical Gel Formulation of Recombinant Human Platelet-Derived Growth Factor-BB (Becaplermin) in Patients With Chronic Neuropathic Diabetic Ulcers: A phase III randomized placebo-controlled double-blind study

4. Graftskin, a Human Skin Equivalent, Is Effective in the Management of Noninfected Neuropathic Diabetic Foot Ulcers

5. The Efficacy and Safety of Dermagraft in Improving the Healing of Chronic Diabetic Foot Ulcers